CLYM

4.58

9.05% 0.38

Dopo l'orario di chiusura: 4.50 -0.08 -1.75%

Climb Bio Inc (CLYM)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$4.20

Aprire:

$4.29

Volume 24 ore:

1.40M

Relative Volume:

1.09

Capitalizzazione di mercato:

$312.28M

Reddito:

Utile/perdita netta:

$-64.20M

Rapporto P/E:

-2.1302

EPS:

-2.15

Flusso di cassa netto:

$57,000

1 W Prestazione:

+14.50%

1M Prestazione:

+153.04%

6M Prestazione:

+263.49%

1 anno Prestazione:

+144.92%

Intervallo 1D:

$4.26

$4.978

Intervallo di 1 settimana:

$3.46

$4.978

Portata 52W:

$1.05

$5.048

Climb Bio Inc Stock (CLYM) Company Profile

Nome

Climb Bio Inc

Settore

Healthcare (1113)

Industria

Biotechnology (621)

Telefono

1-866-857-2596

Indirizzo

20 WILLIAM STREET, WELLESLEY HILLS

Dipendente

Cinguettio

Prossima data di guadagno

2025-03-04

Ultimi documenti SEC

CLYM's Discussions on Twitter

Confronta CLYM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLYM Climb Bio Inc	4.58	286.37M	0	-64.20M	57,000	-2.15
VRTX Vertex Pharmaceuticals Inc	469.68	122.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	801.01	85.37B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	399.40	55.82B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	795.57	50.67B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	170.27	37.54B	447.02M	-1.18B	-906.14M	-6.1812

Climb Bio Inc Stock (CLYM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-16	Iniziato	William Blair	Outperform
2025-10-13	Iniziato	H.C. Wainwright	Buy
2025-08-15	Iniziato	Robert W. Baird	Outperform
2025-06-06	Iniziato	Oppenheimer	Outperform
2025-05-22	Iniziato	BTIG Research	Buy
2024-12-02	Iniziato	Leerink Partners	Outperform

Mostra tutto

Climb Bio Inc Borsa (CLYM) Ultime notizie

Jan 08, 2026

Is Climb Bio Inc. stock oversold or undervaluedProfit Target & Low Risk High Reward Ideas - ulpravda.ru

Jan 08, 2026

How Climb Bio Inc. stock reacts to oil pricesTreasury Yields & Free Weekly Watchlist of Top Performers - ulpravda.ru

Jan 08, 2026

Climb Bio advances clinical trials with first patients dosed in key studies - Investing.com Australia

Jan 08, 2026

Climb Bio outlines 2026 clinical milestones and cash runway - TipRanks

Jan 08, 2026

Climb Bio advances clinical trials with first patients dosed in key studies By Investing.com - Investing.com South Africa

Jan 08, 2026

Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026 - TradingView — Track All Markets

Jan 08, 2026

Jan 07, 2026

Climb Bio Inc Stock Analysis and ForecastSector Performance Review & Explosive Capital Growth Plans - earlytimes.in

Jan 05, 2026

Jan 03, 2026

Setup Watch: Will SBUX stock benefit from commodity pricesPortfolio Value Summary & AI Driven Price Forecasts - moha.gov.vn

Jan 03, 2026

Jan 02, 2026

Alumis issues breach notice to Climb Bio over $3 million milestone payment - Investing.com Nigeria

Jan 02, 2026

Climb Bio appoints Edgar D. Charles as Chief Medical Officer - MSN

Jan 02, 2026

Alumis IncCo & Its Unit Issues Notice Of Material Breach & Notification Of Claim For Indemnification To Climb BioSEC Filing - TradingView — Track All Markets

Jan 02, 2026

Alumis issues breach notice to Climb Bio over $3 million milestone payment By Investing.com - Investing.com South Africa

Jan 02, 2026

Alumis Inc. Issues Notice of Material Breach to Climb Bio - TradingView — Track All Markets

Jan 02, 2026

Jan 01, 2026

Climb Bio challenges Alumis milestone and royalty obligations - MSN

Jan 01, 2026

Dec 31, 2025

HC Wainwright forecasts 2026 data readouts for Climb Bio’s (CLYM) Budoprutug across clinical tracks - MSN

Dec 31, 2025

Climb Bio files complaint against Alumis and AcelyrinSEC filing - MarketScreener

Dec 31, 2025

Climb Bio Challenges Alumis Milestone and Royalty Obligations - TipRanks

Dec 31, 2025

Climb Bio, Inc. Files Legal Complaint Over Asset Purchase Agreement - TradingView — Track All Markets

Dec 31, 2025

H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio’s (CLYM) Budoprutug Across Clinical Tracks - Insider Monkey

Dec 31, 2025

Dec 30, 2025

Climb Bio initiated with a buy at Freedom Capital - MSN

Dec 30, 2025

Freedom Capital Markets initiates Buy rating on Climb Bio stock with $9 target - Investing.com Canada

Dec 30, 2025

Climb Bio initiated with a Buy at Freedom Capital - TipRanks

Dec 30, 2025

Dec 29, 2025

Apollo Tyres Limited Stock Poised for Technical ComebackTrading Psychology Tips & Outstanding Investment Portfolio - bollywoodhelpline.com

Dec 29, 2025

10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey

Dec 29, 2025

Dec 28, 2025

Here's Why We're Watching Climb Bio's (NASDAQ:CLYM) Cash Burn Situation - Yahoo Finance

Dec 28, 2025

Climb Bio price target raised to $11 from $9 at HC Wainwright - MSN

Dec 28, 2025

Retail investors in Climb Bio, Inc. (NASDAQ:CLYM) are its biggest bettors, and their bets paid off as stock gained 15% last week - simplywall.st

Dec 28, 2025

Dec 27, 2025

Vilin Bio Med Limited Breaks Losing Streak — Is the Trend ReversingStock Split Announcements & Rapid Wealth Accumulation - bollywoodhelpline.com

Dec 27, 2025

AI Indicators Detect Buy Opportunity in Shree OSFM ESupport and Resistance Levels & Build a Smarter Portfolio Right Now - bollywoodhelpline.com

Dec 27, 2025

Dec 26, 2025

Candlestick Signal Suggests Reversal in Rajputana Industries LimitedTechnical Resistance Breaks & Accelerated Capital Growth - bollywoodhelpline.com

Dec 26, 2025

Dec 22, 2025

HC Wainwright Reduces Earnings Estimates for Climb Bio - MarketBeat

Dec 22, 2025

Dec 20, 2025

Can Climb Bio Inc. stock deliver sustainable ROE2025 Growth vs Value & Consistent Profit Trade Alerts - Улправда

Dec 20, 2025

Climb Bio Earnings Notes - Trefis

Dec 20, 2025

Dec 19, 2025